<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Danchin, Nicolas</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">STEMI Mortality Decreases in France While Some Key Risk Factors Increase</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-20</style></pages><abstract><style  face="normal" font="default" size="100%">The overall rate of cardiovascular (CV) mortality among patients with ST-segment elevation myocardial infarction (STEMI) in France has decreased 68% over the past 15 years, but the profile of patients hospitalized for STEMI has changed, with a higher prevalence of younger patients with no comorbidities or history of CV disease. This article reviews data from 4 nationwide French registries (USIK 1995, USIC [Unite′ de Soins Intensifs Coronaires] 2000, FAST-MI [French Registry of Acute Coronary Syndrome With or Without ST Elevation; NCT00673036] 2005, and FAST-MI 2010 [NCT01237418]), with 1-month surveys conducted every 5 years from 1995 to 2010.</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>